Literature DB >> 9579924

Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom.

B van Hout1, D Gagnon, E Souêtre, S Ried, C Remy, G Baker, P Genton, H Vespignani, P McNulty.   

Abstract

PURPOSE: The relationship between seizure frequency and both health care costs and quality of life (QOL) was investigated in a retrospective, cross-sectional, multicenter study in France, Germany, and the United Kingdom.
METHODS: Three hundred outpatients with stable partial epilepsy were approximately evenly distributed among five seizure-frequency groups, ranging from seizure-free in the last 3 months (group 1) to daily seizures (group 5). Economic data, obtained through patient interviews and record abstraction, comprised direct medical costs, direct nonmedical costs, and indirect costs for the preceding 3 months. Total societal costs in the three countries were pooled and converted to United States dollar equivalents. QOL was assessed through a self-administered questionnaire, the Functional Status Questionnaire (FSQ).
RESULTS: Mean total costs increased from $780 in group 1 to $2,171 in group 5 (p = 0.0001), with significant increases in each cost category as seizure frequency increased. Greater seizure frequency also significantly (p = 0.0270) correlated with lower employment rates, which ranged from 57% in group 1 to 30% in group 5. QOL declined as seizure frequency increased. Particularly affected were basic and intermediate activities of daily living (ADL), mental health, social activity, and feeling about health.
CONCLUSIONS: The study results show that higher seizure frequencies are associated with higher direct and indirect costs and with reduced QOL for patients with epilepsy.

Entities:  

Mesh:

Year:  1997        PMID: 9579924     DOI: 10.1111/j.1528-1157.1997.tb01220.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  16 in total

1.  The cost effectiveness of two new antiepileptic therapies in the absence of direct comparative data: a first approximation.

Authors:  Ben A van Hout; Dennis D Gagnon; Pauline McNulty; Anthony O'Hagan
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Economic burden of epilepsy among the privately insured in the US.

Authors:  Jasmina I Ivanova; Howard G Birnbaum; Yohanne Kidolezi; Ying Qiu; David Mallett; Sue Caleo
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  Seizure severity is associated with poor quality of life in people living with epilepsy (PLWE) in Uganda: A cross-sectional study.

Authors:  Mark Kaddumukasa; Levicatus Mugenyi; Samden Lhatoo; Nelson Sewankambo; Carol Blixen; Martha Sajatovic; Elly Katabira
Journal:  Epilepsy Behav       Date:  2019-05-21       Impact factor: 2.937

Review 4.  Economic and health-related quality of life considerations of new therapies in Parkinson's disease.

Authors:  L M Rubenstein; A DeLeo; E A Chrischilles
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 5.  Quality of life in patients with epilepsy and impact of treatments.

Authors:  Patrizia Berto
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

6.  Cost-of-illness of epilepsy in Italy. Data from a multicentre observational study (Episcreen).

Authors:  P Berto; P Tinuper; S Viaggi
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

Review 7.  Prescribing antiepileptic drugs: should patients be switched on the basis of cost?

Authors:  Barbara C Jobst; Gregory L Holmes
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

8.  The size, burden and cost of disorders of the brain in the UK.

Authors:  Naomi A Fineberg; Peter M Haddad; Lewis Carpenter; Brenda Gannon; Rachel Sharpe; Allan H Young; Eileen Joyce; James Rowe; David Wellsted; David J Nutt; Barbara J Sahakian
Journal:  J Psychopharmacol       Date:  2013-07-24       Impact factor: 4.153

9.  Seizure frequency and severity: How really important are they for the quality of life of patients with refractory epilepsy.

Authors:  Ekaterina Ivanova Viteva
Journal:  Ann Indian Acad Neurol       Date:  2014-01       Impact factor: 1.383

10.  Cost of Illness of Epilepsy and Associated Factors in Patients Attending Adult Outpatient Department of University of Gondar Referral Hospital, Northwest Ethiopia.

Authors:  Piniel Melkamu; Yaregal Animut; Amare Minyihun; Asmamaw Atnafu; Mezgebu Yitayal
Journal:  Risk Manag Healthc Policy       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.